Viewing Study NCT02356458


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-04-17 @ 12:44 AM
Study NCT ID: NCT02356458
Status: TERMINATED
Last Update Posted: 2022-03-11
First Post: 2015-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
Sponsor: Swiss Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module